A consortium of life sciences companies including Novartis, Bristol Myers Squibb and GSK have united to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19.
Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.
The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.
Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.
An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve.
The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.
Biotech Thermo Fisher Scientific has announced plans to acquire Dutch diagnostics group Qiagen for $11.5 billion.
A Utah jury has found a former Becton Dickinson research engineer not guilty of stealing trade secrets covering the medical device company’s antiseptic products.
Gareth Probert, the former head of HGF’s Nottingham, UK office, has joined EIP to strengthen its medtech and healthcare practice.